Common Prescription Drug May Boost Melanoma Immunotherapy

News   Jan 09, 2018 | Original story from Penn State

 
Common Prescription Drug May Boost Melanoma Immunotherapy
 
 
 

RELATED ARTICLES

Lunaphore and Vitro Sign Collaboration Agreement

News

Companies announce a collaboration agreement to develop In Situ Hybridization (ISH) protocols for RNA and DNA targets in tissue using reagents provided by Vitro on Lunaphore’s rapid autostaining platform.

READ MORE

Carcinogen Hazard From BBQ Smoke

News

Primary exposure to carcinogenic PAHs is through diet, however new research shows that skin was the second-highest exposure route, with barbecue smoke one of the main culprits.

READ MORE

Worldwide Clinical Trials Receives 2018 CRO Leadership Awards

News

Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE